IYH holdings and overlap
iShares U.S. Healthcare ETF (IYH) holds 100 positions in its iShares file of 2026-10-27. Its three largest are Eli Lilly (LLY) at 15.29%, Johnson & Johnson (JNJ) at 9.67% and AbbVie (ABBV) at 7.57%, and its ten largest make up 58.9% of the fund.
In its iShares file of 2026-10-27, IYH is 99.8% health care by sector, with none of it in mega-cap tech or in the ten largest US companies by market value.
What does IYH hold, as of its issuer file of 2026-10-27?
Eli Lilly is 15.29% of IYH on its own, against a median largest position of 8.6% across the 28 Health Care funds with a page here. The position IYH carries furthest above that group is Johnson & Johnson at 9.67% of the fund, a company the median fund in that group does not hold at all.
| Rank | Company | Weight | Weight bar |
|---|---|---|---|
| 1 | LLY Eli Lilly | 15.29% | |
| 2 | JNJ Johnson & Johnson | 9.67% | |
| 3 | ABBV AbbVie | 7.57% | |
| 4 | UNH UnitedHealth Group | 5.53% | |
| 5 | MRK Merck | 5.24% | |
| 6 | TMO Thermo Fisher Scientific | 3.85% | |
| 7 | AMGN Amgen | 3.61% | |
| 8 | GILD Gilead Sciences | 2.95% | |
| 9 | ABT Abbott Laboratories | 2.67% | |
| 10 | PFE Pfizer | 2.53% | |
| 11 | ISRG Intuitive Surgical | 2.35% | |
| 12 | DHR Danaher | 2.19% | |
| 13 | VRTX Vertex Pharmaceuticals | 1.98% | |
| 14 | BMY Bristol Myers Squibb | 1.88% | |
| 15 | MDT Medtronic | 1.72% | |
| 16 | SYK Stryker | 1.56% | |
| 17 | ELV Elevance Health | 1.37% | |
| 18 | REGN Regeneron Pharmaceuticals | 1.21% | |
| 19 | CI Cigna | 1.16% | |
| 20 | MRNA Moderna | 1.13% | |
| 21 | BSX Boston Scientific | 1.0% | |
| 22 | HCA HCA Healthcare | 0.98% | |
| 23 | NTRA Natera | 0.84% | |
| 24 | BDX Becton Dickinson | 0.8% | |
| 25 | EW Edwards Lifesciences | 0.77% | |
| 26 | A Agilent Technologies | 0.75% | |
| 27 | HUM Humana | 0.74% | |
| 28 | VEEV Veeva Systems | 0.7% | |
| 29 | WAT Waters | 0.69% | |
| 30 | IDXX Idexx Laboratories | 0.66% | |
| 31 | IQV IQVIA | 0.66% | |
| 32 | ILMN Illumina | 0.63% | |
| 33 | BIIB Biogen | 0.56% | |
| 34 | RMD ResMed | 0.54% | |
| 35 | RVMD Revolution Medicines | 0.53% | |
| 36 | CNC Centene | 0.51% | |
| 37 | ZTS Zoetis | 0.49% | |
| 38 | GEHC GE HealthCare | 0.48% | |
| 39 | ALNY Alnylam Pharmaceuticals | 0.45% | |
| 40 | DXCM Dexcom | 0.44% | |
| 41 | WST West Pharmaceutical Services | 0.42% | |
| 42 | LH Labcorp | 0.41% | |
| 43 | RPRX Royalty Pharma | 0.4% | |
| 44 | DGX Quest Diagnostics | 0.4% | |
| 45 | UTHR United Therapeutics | 0.37% | |
| 46 | GH Guardant Health | 0.34% | |
| 47 | STE Steris | 0.33% | |
| 48 | VTRS Viatris | 0.33% | |
| 49 | THC Tenet Healthcare | 0.31% | |
| 50 | INSM Insmed | 0.3% | |
| 51 | INCY Incyte | 0.29% | |
| 52 | ROIV Roivant Sciences | 0.28% | |
| 53 | ZBH Zimmer Biomet | 0.28% | |
| 54 | RVTY Revvity | 0.27% | |
| 55 | CRL Charles River Laboratories | 0.26% | |
| 56 | EXEL Exelixis | 0.24% | |
| 57 | MEDP Medpace | 0.23% | |
| 58 | HALO Halozyme Therapeutics | 0.23% | |
| 59 | MDLN Medline | 0.22% | |
| 60 | NBIX Neurocrine Biosciences | 0.22% | |
| 61 | ASND Ascendis Pharma A/S | 0.2% | |
| 62 | BAX Baxter International | 0.19% | |
| 63 | PEN Penumbra | 0.18% | |
| 64 | JAZZ Jazz Pharmaceuticals | 0.18% | |
| 65 | SOLV Solventum | 0.18% | |
| 66 | EHC Encompass Health | 0.18% | |
| 67 | BBIO BridgeBio Pharma | 0.17% | |
| 68 | COO Cooper Companies | 0.17% | |
| 69 | TECH Bio-Techne | 0.17% | |
| 70 | AVTR Avantor | 0.17% | |
| 71 | ELAN Elanco Animal Health | 0.17% | |
| 72 | BMRN BioMarin Pharmaceutical | 0.16% | |
| 73 | RGEN Repligen | 0.16% | |
| 74 | PODD Insulet | 0.15% | |
| 75 | QGEN Qiagen | 0.15% | |
| 76 | MOH Molina Healthcare | 0.15% | |
| 77 | ALGN Align Technology | 0.15% | |
| 78 | ENSG The Ensign Group | 0.14% | |
| 79 | GMED Globus Medical | 0.14% | |
| 80 | UHS Universal Health Services | 0.13% | |
| 81 | CORT Corcept Therapeutics | 0.12% | |
| 82 | HSIC Henry Schein | 0.12% | |
| 83 | ARWR Arrowhead Pharmaceuticals | 0.12% | |
| 84 | MDGL Madrigal Pharmaceuticals | 0.12% | |
| 85 | TEM Tempus AI | 0.12% | |
| 86 | IONS Ionis Pharmaceuticals | 0.11% | |
| 87 | BIO Bio-Rad Laboratories | 0.1% | |
| 88 | BRKR Bruker | 0.1% | |
| 89 | CHE Chemed | 0.1% | |
| 90 | DVA DaVita | 0.09% | |
| 91 | TFX Teleflex | 0.09% | |
| 92 | AXSM Axsome Therapeutics | 0.09% | |
| 93 | SHC Sotera Health | 0.08% | |
| 94 | DOCS Doximity | 0.06% | |
| 95 | CAI Caris Life Sciences | 0.06% | |
| 96 | NVST Envista | 0.06% | |
| 97 | OGN Organon | 0.05% | |
| 98 | VKTX Viking Therapeutics | 0.04% | |
| 99 | SMMT Summit Therapeutics | 0.03% | |
| 100 | HOLX Hologic Inc | 0.0% |
The most recent file iShares has published for IYH is dated 2026-10-27, 1 day before these prices, which is the median for the iShares ETFs covered here. Every one of the 100 positions IYH holds, with its weight, is in the fund's JSON file. See the other 118 ETFs with a page here that hold LLY, and how their weights compare with the 15.29% IYH gives it.
Category: Health Care, set by TickerInside from the ETF's own latest file. In its file of 2026-10-27, 100% of its stocks whose sector is known are health care companies, each in the sector the site gives that company. How categories are set.
https://tickerinside.com/api/v1/fund/iyh.jsonhttps://tickerinside.com/api/v1/fund/iyh.csv=IMPORTDATA("https://tickerinside.com/api/v1/fund/iyh.csv")If your sheet uses a decimal comma: =IMPORTDATA("https://tickerinside.com/api/v1/fund/iyh.csv"; ","; "en_US")curl -s https://tickerinside.com/api/v1/fund/iyh.jsonHow much money went into or out of IYH?
On the close of Friday, October 23, 2026, $3.8 million came out of IYH, 0.08% of its assets, as it redeemed shares. Over its last 5 closes, a net inflow of $63 million.
From IYH's own holdings files. Every ETF's latest flows.
How is IYH split by sector?
| Sector | Weight | Weight bar |
|---|---|---|
| Health care | 99.8% |
From its iShares file of 2026-10-27. How these are measured.
What did IYH hold in its SEC reports since 2019?
In IYH's SEC filings, its largest position went from Johnson & Johnson (JNJ) at 9.09% on 2019-10-31 to Lilly (Eli) (LLY) at 15.11% on 2026-07-31, across 27 quarterly reports.
| Report | Positions | Largest | Top 10 |
|---|---|---|---|
| 2019-10-31 | 117 | JNJ 9.09% | 46.4% |
| 2020-10-31 | 116 | JNJ 8.57% | 46.8% |
| 2021-10-31 | 114 | UNH 7.97% | 47.5% |
| 2022-10-31 | 111 | UNH 10.14% | 53.9% |
| 2023-10-31 | 114 | UNH 10.38% | 54.3% |
| 2024-10-31 | 107 | LLY 11.86% | 55.4% |
| 2025-10-31 | 103 | LLY 12.70% | 54.9% |
| 2026-07-31 | 100 | LLY 15.11% | 59.0% |
The first report, then the last of each year, of the 27 reports IYH filed on SEC Form N-PORT from 2019-10-31 to 2026-07-31, each company under its ticker today. Every position of every report is in its quarterly file, and at any date at /api/v1/history/iyh/{date}.json. How these are read.
What does IYH duplicate?
The ETF nearest to IYH is XLV: the two hold 91.2% of their weight in common, in the 55 companies both own, and 91.4% of IYH itself is also held there. Owning IYH alongside the ETFs at the top of this table means holding mostly the same companies twice.
| ETF | Overlap by weight | Of IYH held there | Of that ETF in IYH | Companies in both | Overlap bar |
|---|---|---|---|---|---|
| XLV | 91.2% | 91.4% | 94.1% | 55 | |
| VHT | 86.6% | 99.2% | 87.8% | 95 | |
| IXJ | 68.7% | 91.4% | 68.9% | 56 | |
| RSPH | 46.9% | 91.4% | 91.6% | 55 | |
| PJP | 38.6% | 54.3% | 65.7% | 15 | |
| IHE | 35.5% | 36.5% | 84.4% | 13 | |
| PPH | 35.3% | 43.7% | 54.4% | 13 | |
| BMED | 34.6% | 52.2% | 74.9% | 30 | |
| CANC | 21.7% | 49.9% | 38.4% | 15 | |
| XT | 20.0% | 62.2% | 20.1% | 25 | |
| FMED | 19.0% | 37.8% | 44.6% | 24 | |
| IBB | 17.9% | 17.9% | 68.4% | 32 |
The holdings of VHT and CANC are from their SEC Form N-PORT filings for the period ended 2026-05-31, filed 2026-07-29. PPH's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26. FMED's holdings are from its SEC Form N-PORT for the period ended 2026-08-31, filed 2026-10-26. The other ETFs' holdings are from their issuers' latest files. Check IYH against any ETF in the ETF overlap calculator · how overlap is measured.
What adds something different to IYH?
SOXX shares 0% of weight with IYH and its weekly returns correlate with it at 0.14 over three years. The table lists the covered ETFs with the least in common with IYH, least shared weight first and, among equals, lowest correlation.
| ETF | Name | Overlap by weight | Correlation, 3y | Companies in both |
|---|---|---|---|---|
| SOXX | iShares Semiconductor ETF | 0.0% | 0.14 | 0 |
| MCHI | iShares MSCI China ETF | 0.0% | 0.17 | 0 |
| SLVP | iShares MSCI Global Silver and Metals Miners ETF | 0.0% | 0.22 | 0 |
| PFF | iShares Preferred and Income Securities ETF | 0.0% | 0.26 | 0 |
| RING | iShares MSCI Global Gold Miners ETF | 0.0% | 0.27 | 0 |
| PICK | iShares MSCI Global Metals & Mining Producers ETF | 0.0% | 0.35 | 0 |
| SCZ | iShares MSCI EAFE Small-Cap ETF | 0.0% | 0.46 | 0 |
| USRT | iShares Core U.S. REIT ETF | 0.0% | 0.53 | 0 |
Cost, returns and risk
| Expense ratio | 0.37% |
|---|---|
| Dividend yield | 1.12% |
| Total return, 1 year | 26.1% |
| Total return, 3 years cumulative | 47.7% |
| Total return, 5 years cumulative | 40.0% |
| Volatility, annualised | 14.9% |
| Worst fall, 3 years | -17.1% |
| Beta against SPY, 3 years of weekly returns | 0.42 |
| Weight in the ten largest positions | 58.9% |
| Largest single position | 15.3% |
| Assets under management | $4.0B |
Expense ratio, yield and assets are reference data (the expense ratio from IYH's SEC filing of 2026-08-21); the weight in the ten largest positions and the largest single position are from the issuer file of 2026-10-27; every other figure is computed here from weekly closes.
How it moves with the market
| Against | Correlation, 3 years | Covariance, annualised, in percent squared |
|---|---|---|
| SPY | 0.39barely linked | 81 |
| QQQ | 0.21barely linked | 61 |
Weekly total returns. What the bands mean · why the covariance is printed.
Year by year
| Year | Total return |
|---|---|
| 2026 | 17.5% |
| 2025 | 13.2% |
| 2024 | 3.0% |
| 2023 | 2.1% |
| 2022 | -4.5% |
One year
Where to go next
- PBE, Invesco Biotechnology & Genome ETF
- PJP, Invesco Pharmaceuticals ETF
- PPH, VanEck Pharmaceutical ETF
- PSCH, Invesco S&P SmallCap Health Care ETF
- Run a portfolio x-ray to see what IYH carries once you look through it
- Compare IYH against any other ETF in the builder
Holdings from the most recent file iShares has published, dated 2026-10-27. Prices through 2026-10-28. How every figure here is produced. Measurements, not investment advice.
Cite this page
TickerInside, iShares U.S. Healthcare ETF (IYH), holdings from the issuer's file of 2026-10-27, https://tickerinside.com/etf/iyh/, CC BY 4.0
<a href="https://tickerinside.com/etf/iyh/">TickerInside</a> (https://tickerinside.com/etf/iyh/)